Precision Drilling
PDS
Lantheus
LNTH
eBay
EBAY
4
DexCom
DXCM
5
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 365.91%35.99M | 195.65%7.89M | 534.63%13.84M | 172.47%3.46M | 501.56%10.81M | -700.47%-13.54M | -232.61%-8.25M | -54.07%2.18M | -64.64%-4.77M | -154.59%-2.69M |
Net income from continuing operations | 13.19%61.64M | 105.07%14.51M | -1.78%15.8M | 7.78%16.19M | -6.98%15.14M | -19.64%54.46M | -64.05%7.08M | 9.17%16.09M | -12.98%15.02M | 1.14%16.28M |
Operating gains losses | -1,506.71%-8.15M | ---3.36M | ---3.45M | ---1.28M | 88.76%-57K | 32.67%-507K | --0 | --0 | --0 | ---507K |
Depreciation and amortization | 10.43%1.91M | 12.75%504K | 17.21%504K | 13.37%475K | -1.63%423K | -10.85%1.73M | 118.08%447K | -87.81%430K | -6.89%419K | 0.00%430K |
Deferred tax | 74.81%-132K | ---- | ---- | ---- | ---- | -959.02%-524K | ---- | ---- | ---- | ---- |
Other non cash items | -48.34%-2.01M | -18.21%-383K | -47.35%-557K | 3.11%-343K | -143.77%-724K | -6.37%-1.35M | -220.00%-324K | 53.62%-378K | -10.97%-354K | 27.21%-297K |
Change In working capital | 74.02%-18.06M | 78.11%-3.4M | 111.17%1.68M | 39.74%-12.18M | 77.87%-4.15M | 6.30%-69.51M | 19.97%-15.54M | -14.73%-15M | 1.91%-20.21M | 11.02%-18.76M |
-Change in receivables | 68.78%-17.71M | 57.01%-3.5M | 75.76%-4.25M | 63.75%-6.52M | 73.65%-3.44M | -8.10%-56.71M | 48.67%-8.13M | -51.76%-17.54M | -26.17%-18M | -20.78%-13.04M |
-Change in inventory | 169.20%3.38M | -41.21%562K | 273.39%2.85M | 356.83%3.29M | -14.07%-3.33M | 76.57%-4.89M | 131.12%956K | 55.79%-1.65M | 61.49%-1.28M | 72.84%-2.92M |
-Change in prepaid assets | 19.50%-1.07M | -1,353.45%-2.18M | 296.44%2.38M | 14.84%-505K | -347.21%-754K | -372.78%-1.32M | 155.88%174K | -546.13%-1.21M | -144.03%-593K | -21.59%305K |
-Change in payables and accrued expense | -69,640.00%-3.49M | 147.23%2.42M | -111.81%-827K | -191.96%-5.85M | 608.26%772K | 99.85%-5K | -1,147.56%-5.12M | 635.71%7M | 71.28%-2M | -96.41%109K |
-Change in other current assets | 297.53%2.4M | 167.02%823K | 13,660.00%688K | -252.14%-855K | 415.22%1.74M | 13.54%-1.21M | -140.69%-1.23M | 103.21%5K | 371.50%562K | 86.40%-552K |
-Change in other current liabilities | 222.56%629K | 81.96%1.61M | -257.07%-2.02M | 583.50%996K | -50.00%40K | -83.47%195K | 192.30%887K | -167.62%-566K | -119.75%-206K | -69.35%80K |
-Change in other working capital | 60.44%-2.2M | -1.82%-3.14M | 374.02%2.86M | -308.87%-2.73M | 129.54%812K | -345.44%-5.57M | -38.84%-3.09M | -440.85%-1.04M | -61.16%1.31M | -436.47%-2.75M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 365.91%35.99M | 195.65%7.89M | 534.63%13.84M | 172.47%3.46M | 501.56%10.81M | -700.47%-13.54M | -232.61%-8.25M | -54.07%2.18M | -64.64%-4.77M | -154.59%-2.69M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 31.27%-6.71M | -135.11%-5.2M | 68.22%-3.65M | -109.46%-579K | 224.47%2.72M | -207.58%-9.77M | 74.01%-2.21M | -252.77%-11.49M | -16.33%6.12M | -179.38%-2.19M |
Net PPE purchase and sale | -15.65%-7.64M | 39.86%-1.89M | -55.35%-4.72M | 76.03%-186K | -344.67%-849K | -212.15%-6.61M | -372.66%-3.14M | -72.25%-3.04M | -20.68%-776K | 140.21%347K |
Net investment purchase and sale | --0 | --0 | --0 | ---- | ---- | 201.36%8.5M | --0 | --0 | ---- | ---- |
Net other investing changes | 107.93%925K | -457.11%-3.31M | 112.56%1.06M | 75.45%-393K | 240.94%3.57M | -159.56%-11.66M | 172.50%928K | -191.09%-8.46M | -120.11%-1.6M | -170.03%-2.53M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 31.27%-6.71M | -135.11%-5.2M | 68.22%-3.65M | -109.46%-579K | 224.47%2.72M | -207.58%-9.77M | 74.01%-2.21M | -252.77%-11.49M | -16.33%6.12M | -179.38%-2.19M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -235.99%-28.88M | -119.79%-2.11M | -216.14%-9.67M | -12.75%-3.44M | -358.01%-13.65M | 478.25%21.24M | 319.14%10.67M | 154.55%8.33M | -141.69%-3.05M | 2,608.06%5.29M |
Net issuance payments of debt | -212.04%-23.68M | -119.79%-2.11M | -217.07%-9.75M | 102.03%64K | -324.55%-11.88M | 476.47%21.14M | 319.14%10.67M | 165.35%8.33M | -142.02%-3.15M | 281.42%5.29M |
Net common stock issuance | ---5.4M | --0 | ---22K | ---3.51M | ---1.87M | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | 100.00%200K | --0 | --100K | --0 | --100K | --100K | --0 | --0 | --100K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -235.99%-28.88M | -119.79%-2.11M | -216.14%-9.67M | -12.75%-3.44M | -358.01%-13.65M | 478.25%21.24M | 319.14%10.67M | 154.55%8.33M | -141.69%-3.05M | 2,608.06%5.29M |
Net cash flow | ||||||||||
Beginning cash position | -73.46%748K | 4.20%570K | -96.08%60K | -80.79%621K | -73.46%748K | 170.44%2.82M | -95.15%547K | -89.27%1.53M | 27.89%3.23M | 170.44%2.82M |
Current changes in cash | 119.37%401K | 186.63%579K | 151.78%510K | 67.04%-561K | -130.60%-127K | -216.55%-2.07M | 102.39%202K | 67.16%-985K | -114.50%-1.7M | -72.07%415K |
End cash Position | 53.61%1.15M | 53.61%1.15M | 4.20%570K | -96.08%60K | -80.79%621K | -73.46%748K | -73.46%748K | -95.15%547K | -89.27%1.53M | 27.89%3.23M |
Free cash flow | 226.03%26.78M | 152.70%6M | 1,166.67%9.12M | 131.03%1.72M | 387.80%9.94M | -286.98%-21.25M | -278.13%-11.39M | -128.65%-855K | -56.66%-5.55M | -79.79%-3.45M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |